Phreesia Announces Third Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter...
Month: December 2024
Oracle Announces Fiscal 2025 Second Quarter Financial Results
Q2 GAAP Earnings per Share up 24% to $1.10, Non-GAAP Earnings per Share up 10% to $1.47 Q2 Total Revenue...
Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and...
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 4Q24, an Increase of 2 Cents Over 3Q24, and an Aggregate of $5.19 per Common Share for 2024, an Increase of 23 Cents, or 5 Percent, Over 2023
PASADENA, Calif., Dec. 9, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that its Board of...
Roadzen Chosen by One of the World’s Largest LPG Carriers to Bring AI to its Fleet for Road Safety and Compliance
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in...
Omnicell Announces OmniSphere
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery...
Crane Company Announces Promotion of Alejandro (Alex) Alcala to Chief Operating Officer
STAMFORD, Conn.--(BUSINESS WIRE)--Crane Company (NYSE:CR) (“Crane” or the “Company”), a premier industrial manufacturing and technology company, has promoted Alejandro (Alex)...
Bitfarms Announces Restatement of Previously Issued Financial Statements
This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated...
TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition
To date, event-free survival strongly favors the treatment arm (HR=0.30; p=0.04), and treatment-arm patients trend towards lower probability of relapse...
Reminder to Join Olin Corporation’s Investor Day on December 12, 2024
CLAYTON, Mo. , Dec. 9, 2024 /PRNewswire/ -- As previously announced, Olin Corporation (NYSE: OLN) will host an Investor Day...
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
Durable responses are rapid and deepen on treatment as demonstrated by an initial 75.5% Objective Response Rate which increased to...
DynaResource Announces Postponement of Annual Meeting of Stockholders
Irving, Texas--(Newsfile Corp. - December 9, 2024) - DYNR-DynaResource, Inc. (OTCQX: DYNR) ("DynaResource", or "Company") today announced that due to...
Celanese Announces Leadership Transition
DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced that Scott Richardson, currently Celanese’s Chief...
Borr Drilling Limited – Contracting update
HAMILTON, Bermuda, Dec. 9, 2024 /PRNewswire/ -- Borr Drilling Limited (NYSE: BORR) (OSE: BORR) is pleased to announce a new contract...
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Thomas Andrew Garner has been appointed Chief Commercial Officer, effective...
Vail Resorts Reports Fiscal 2025 First Quarter and Season Pass Sales Results, and Announces 2025 Capital Plan
BROOMFIELD, Colo., Dec. 9, 2024 /PRNewswire/ -- Vail Resorts, Inc. (NYSE: MTN) today reported results for the first quarter of fiscal...
Heritage Insurance Holdings Announces Share Repurchase Program
TAMPA, Fla., Dec. 9, 2024 /PRNewswire/ -- Heritage Insurance Holdings, Inc. (NYSE: HRTG) ("Heritage" or the "Company"), a super-regional property and...
The Good Flour Corp. Announces Availability of Annual General Meeting Materials
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - The Good Flour Corp. (CSE: GFCO) (OTC Pink: GFCOF) (FSE: 3KZ)...
Devon Energy President and CEO, Rick Muncrief, to Retire March 1, 2025; Clay Gaspar, Devon Chief Operating Officer, to Succeed Muncrief
OKLAHOMA CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Rick Muncrief, 66, has announced his retirement from the position of President...
Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
Preliminary data supports BMF-500’s potential as a transformative therapy for patients with FLT3 mutated relapsed or refractory (R/R) acute leukemiaBMF-500...
Alta Copper Invites Individual and Institutional Investors, as Well as Advisors and Analysts, to Attend Online at VirtualInvestorConferences.com
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Alta Copper Corp. (TSX: ATCU; OTCQX: ATCUF; BVL: ATCU) (“Alta Copper”...
ZIONS BANCORPORATION ANNOUNCES 2025 EARNINGS RELEASE DATES
SALT LAKE CITY, Dec. 9, 2024 /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ: ZION) announced its expected earnings release dates for the fiscal...
Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
Preliminary data supports BMF-500’s potential as a transformative therapy for patients with FLT3 mutated relapsed or refractory (R/R) acute leukemiaBMF-500...
Toll Brothers Reports FY 2024 Results
FORT WASHINGTON, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation’s leading builder of luxury...
Stem Cell Therapy Market to Worth Over US$ 2,612.92 Million By 2033 | Astute Analytica
New Delhi, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The global stem cell therapy market was valued at US$ 394.50 million...
Signing Day Sports Unveils 2025 U.S. Army Bowl Regional Combine Series Schedule
SCOTTSDALE, Ariz, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American:...
Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash
Basel, 9 December 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for...
Prospect Capital Corporation Hosting Upcoming Webinar: “Preferred Stock as a Low Volatility, Downside Protected, and Income Generating Asset Class”
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) is pleased to...
Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025
HAIFA, Israel, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE:PLUR) ("Pluri" or the “Company"), a leading biotechnology...
Universal Display Corporation Named to Newsweek’s America’s Most Responsible Companies 2025
EWING, N.J.--(BUSINESS WIRE)--Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, announced...
Oil-Dri Announces Record Results for the First Quarter of Fiscal Year 2025
CHICAGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products,...
LM Funding America, Inc. Closes Purchase of 15MW Mining Site
TAMPA, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a...
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
CHMP opinion now expected in 1Q 2025 No Major Objections outstanding; continue to expect Germany launch in 2Q 2025 PITTSBURGH,...
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus
All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion with...
Cencora Closes $1.8 Billion Senior Notes Offering
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of...
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
Potential Approval in Q3 2025 in Recurrent H3 K27M-Mutant Diffuse Glioma Submission Plan Follows Productive and Collaborative Pre-NDA Interactions with...
VICI Properties Announces Pricing of Public Offering of $750 Million of Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)--VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced today that its subsidiary, VICI Properties L.P....
Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium
CAMBRIDGE, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium
SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research...